Search Results - "Hilgard, P."

Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification by Ross, R S, Viazov, S, Salloum, S, Hilgard, P, Gerken, G, Roggendorf, M

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes by Hilgard, Philip, Stockert, Richard

“…Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and…”
Get full text

Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation by Kahraman, A, Witzke, O, Scherag, A, Pütter, C, Miller, M, Dechêne, A, Ross, S R, Gerken, G, Hilgard, P

“…Among patients after renal transplantation (NTx), hepatitis C virus (HCV) infection is a risk factor for graft loss and patient death caused by hepatic…”
Get more information

266 DISTORTED PHYSICAL CHEMISTRY OF HEPATIC BILE IN PATIENTS WITH ISCHEMIC TYPE BILIARY LESIONS (ITBL) AFTER LIVER TRANSPLANTATION by Zimmer, V, Lütjohann, D, Gerken, G, Lammert, F, Hilgard, P

Get full text

597 PRO-AND ANTI-INFLAMMATORY CYTOKINES MODULATE THE CELLULAR UPTAKE OF HEPATITIS C by Tietjens, A.G, Hilgard, P, Dubuisson, J, Schlaak, J.F

Get full text

D-21266, a new heterocyclic alkylphospholipid with antitumour activity by Hilgard, P., Klenner, T., Stekar, J., Nössner, G., Kutscher, B., Engel, J.

“…The aim of this study was to determine the antitumour effects of D-21266 in a rodent tumour model. Hexadecylphosphocholine (INN: Miltefosine) represents the…”
Get full text

Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization by Heusner, T A, Hamami, M E, Ertle, J, Hahn, S, Poeppel, T, Hilgard, P, Bockisch, A, Forsting, M, Antoch, G

“…To retrospectively assess the accuracy of angiography-based C-arm CT for the detection of extrahepatic shunting before SIRT. 30 patients (mean age: 64+/-12…”
Get more information

Selective internal radiotherapy (SIRT) for hepatocellular carcinoma by Antoch, G, Mueller, S P, Hamami, M, Heusner, T A, Ertle, J, Hilgard, P, Forsting, M, Bockisch, A

“…Microsphere-based radioembolization represents a new generation of therapeutics in interventional oncology. The intrahepatic application of radioactive…”
Get more information

51 RESPONSE RATE ACCORDING TO WHO, RECIST AND EASL CRITERIA AFTER RADIOEMBOLIZATION OF YTTRIUM-90 GLASS MICROSPHERES IN ADVANCED HEPATOCELLULAR CARCINOMA: A EUROPEAN PILOT PHASE II STUDY by Fouly, A. El, Ertle, J, Antoch, G, Hamami, M, Paul, A, Bockisch, A, Gerken, G, Hilgard, P

Get full text

370 INTERNAL RADIOTHERAPY WITH 90YTTRIUM GLASS MICROSPHERES (THERASPHERE) FOR LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA: PROSPECTIVE VALIDATION OF SAFETY AND EFFICACY IN A EUROPEAN PILOT STUDY by Ertle, J.M, Antoch, G, Hamami, M, Bockisch, A, Gerken, G, Hilgard, P

Get full text

Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives by Hilgard, P, Müller, S, Hamami, M, Sauerwein, W S, Haberkorn, U, Gerken, G, Antoch, G

“…Microsphere and particle technologies for the selective transport of tumoricidal agents or radiation represent a new generation of therapeutics in…”
Get more information

[460] HCV REPLICATION IS POTENTLY SUPPRESSED BY TLR-STIMULATED NON-PARENCHYMAL LIVER CELLS by Broering, R, Wu, I, Hilgard, P, Lu, M, Gerken, G, Schlaak, J.F

Get full text

965 SENSITIVITY AND SPECIFICITY OF ALPHA-FETO PROTEIN (AFP), LENS CULINARIS AGGLUTININ-REACTIVE AFP (AFP-L3) AND DES- GAMMA-CARBOXYPROTHROMBIN (DCP) AS TUMOR MARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) by Ertle, J.M, Wiehert, M, Küper, R, Hilgard, P, Gerken, G, Schlaak, J

Get full text

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation by CICINNATI, V. R., IACOB, S., KLEIN, C. G., BABA, H. A., SOTIROPOULOS, G. C., HILGARD, P., ERIM, Y., BROELSCH, C. E., GERKEN, G., BECKEBAUM, S.

“…Summary Aim  To investigate the efficacy of two anti‐viral protocols in hepatitis C virus‐reinfected liver transplant recipients. Methods  In this prospective…”
Get full text

Liver Transplantation for Hepatocellular Carcinoma After Yttrium Therapy: A Case Report by Sotiropoulos, G.C, Hilgard, P, Antoch, G, Nowak, K.M, Ertl, J, Fouzas, I, Molmenti, E.P, Sgourakis, G, Beckebaum, S, Paul, A, Broelsch, C.E, Lang, H

“…Abstract Yttrium-90 microspheres constitute one of the most recent treatment options for hepatocellular carcinoma (HCC) in the setting of cirrhosis. As such,…”
Get full text

Alkylphosphocholines : a new class of membrane-active anticancer agents by HILGARD, P, KLENNER, T, STEKAR, J, UNGER, C

Get full text

D-19575 : a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport by POHL, J, BERTRAM, B, HILGARD, P, NOWROUSIAN, M. R, STÜBEN, J, WEISSLER, M

“…D-19575 is a glucose derivative of ifosfamide mustard with a broad spectrum of antitumor activity in animal models. In comparison with ifosfamide, D-19575 is…”
Get full text

3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma by Llovet, J, Mazzaferro, V, Ricci, S, Hilgard, P, Raoul, J, Zeuzem, S, Shan, M, Moscovici, M, Voliotis, D

Get full text

New pharmaceuticals: miltefosine by Hilgard, P

Get more information

Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide by Stekar, J., Hilgard, P., Kienner, T.

“…The effect of pretreatment with miltefosine (MIL) on the antineoplastic activity of cyclophosphamide (CPA) was evaluated in subcutaneous benzo(a)pyrene-induced…”
Get full text